πŸ‡ΊπŸ‡Έ FDA
Patent

US 9428470

Heterocyclic compound

granted A61PA61P3/00A61P3/04

Quick answer

US patent 9428470 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P3/00, A61P3/04, A61P3/10, A61P43/00